Search for: "Schering Plough Corp"
Results 81 - 100
of 154
Sort by Relevance
|
Sort by Date
24 Dec 2009, 11:32 am
Good tidings and great cheer. [read post]
8 Dec 2009, 7:00 pm
EVP and general counsel, Schering-Plough. [read post]
1 Dec 2009, 9:45 am
(patent infringement) 11/25: Schering-Plough Healthcare Products, Inc. v. [read post]
23 Nov 2009, 7:01 pm
Whirlpool Corp. [read post]
9 Nov 2009, 6:01 am
By David Evans Nov. 9 (Bloomberg) -- Prosecutor Michael Loucks remembers clearly when lawyers for Pfizer Inc., the world's largest drug company, looked across the table and promised it wouldn't break the law again. [read post]
22 Oct 2009, 6:02 am
(Editor's Note: This post is based on a Gibson, Dunn & Crutcher LLP memorandum by Amy Goodman and Gillian McPhee.) [read post]
19 Oct 2009, 4:30 am
” In re Schering-Plough Corp. [read post]
27 Sep 2009, 12:38 am
Merck, which is set to buy rival Schering-Plough Corp. by the end of the year, won 11 of 16 Vioxx suits at trial before agreeing to settle all claims. [read post]
30 Aug 2009, 1:00 am
Schering-Plough Corp. v. [read post]
16 Aug 2009, 9:21 pm
Whitehouse Station, New Jersey-based Merck, which is buying rival Schering-Plough Corp., had a reserve of about $42 million for the litigation, including lawyers' fees, it said. [read post]
16 Aug 2009, 2:20 am
" Schering-Plough Corp.'s Marvelon and Cerazette pills, which contain desogestrel, generated $319 million for the Kenilworth, New Jersey-based company in the first quarter, IMS Health data show. [read post]
13 Aug 2009, 9:19 am
Whitehouse Station, New Jersey-based Merck, which is buying rival Schering-Plough Corp., had a reserve of about $42 million for the litigation, including lawyers' fees, it said. [read post]
11 Aug 2009, 3:23 am
Schering-Plough Healthcare Products, Inc. v. [read post]
4 Aug 2009, 1:15 am
Merck, which is buying rival Schering-Plough Corp., had a reserve of about $24 million for the litigation, including lawyers' fees, as of March 31, having spent $9 million on the cases in the first quarter, the company said in May. [read post]
30 Jul 2009, 7:02 am
The same Bloomberg article also re-caps the most recent (albeit a bit dated) information about the extent of this ongoing Fosamax litigation: Merck, which is buying rival Schering-Plough Corp., had a reserve of about $24 million for the litigation, including lawyers' fees, as of March 31, having spent $9 million on the cases in the first quarter, the company said in May. [read post]
23 Jul 2009, 3:15 am
We wouldn't base a motion solely on Actimmune, but with Pennsylvania Employees as the lead case, Actimmune is useful supporting precedent.Another candidate for best supporting actor in this area is In re Schering-Plough Corp. [read post]
22 Jul 2009, 12:32 pm
Louis drug liability lawyer, I was scandalized but not surprised by a recent revelation that Merck & Co. and Schering-Plough Corp. actively suppressed evidence about their drugs' efficacy in order to prtect their bottom lines. [read post]
13 Jul 2009, 9:28 pm
A tip of the old cyberhat - and not for the first time - to Alan Modlinger at Lowenstein Sandler for passing along to us the latest good news on the off-label promotion front - dismissal (with leave to replead under Twombly) in In re Schering-Plough Corp. [read post]
25 Jun 2009, 4:29 am
Genzyme Corp., 2008 WL 2940811 (N.D. [read post]
12 Jun 2009, 12:10 pm
., Schering-Plough Corp. v. [read post]
